Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
BelgiumStudy on the Safety and Effectiveness of Upadacitinib and Prednisolone in Patients with Giant Cell Arteritis
BelgiumStudy on the Effectiveness and Safety of Reparixin for Adults with Acute Respiratory Distress Syndrome
GermanyStudy on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD
PolandStudy on Long-Term Safety and Effectiveness of Liposomal Ciclosporin A for Patients with Bronchiolitis Obliterans Syndrome After Lung Transplantation
AustriaStudy on the Effects of Bezafibrate and Obeticholic Acid for Patients with Primary Biliary Cholangitis
ItalyStudy on Itacitinib for Treating Non-Severe Hemophagocytic Lymphohistiocytosis in Adults
FranceStudy on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis
The NetherlandsStudy on Itacitinib for Adults with Diffuse Systemic Sclerosis
FranceStudy on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis
FranceFranceStudy on the Safety and Effects of OMS906 for Patients with C3 Glomerulopathy and Idiopathic Immune Complex-Mediated Glomerulonephritis
LithuaniaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
